British Patient Capital Interim Evaluation report infographic

British Patient Capital is a driving force for innovation, economic growth and job creation behind scale up Britain



economic benefits likely to be generated by BPC-backed firms by 2030/31

Up to 5,000 jobs

created by BPC-backed funds, equivalent to 55% employment growth for BPC-backed firms

Between £4.7m and £5.4m

increase in turnover per year on average for BPC-backed firms


higher pre-money valuation on average for beneficiary companies than they would have had without BPC-backed funding

Supporting scale up Britain


of BPC-backed firms are later stage growth companies, compared to 9% of all equity-backed companies


of BPC-backed firms said growth would not have been achieved without the investment and a further 50% said growth would have taken longer to achieve

Backing innovation


of surveyed BPC-backed firms are using the equity investment to fund research and development


of surveyed firms receiving BPC-backed investment went on to commercialise new products or services

Science superpower


of BPC-backed companies are academic spinouts, compared to just 2% of all equity-backed companies


of firms are in the technology sector, including Artificial Intelligence and Fintech